Literature DB >> 8545632

The pathophysiology of gastro-oesophageal reflux disease: an overview.

J P Galmiche1, J Janssens.   

Abstract

Gastro-oesophageal reflux disease (GORD) is a multifactorial disease. Although it is primarily a motility disorder, several other disturbances can interfere and contribute to determine the severity of symptoms and the degree of lesions. In normal subjects, as in patients with pathological reflux, nearly all the episodes of reflux obey one of the following three mechanisms: (a) a transient complete relaxation of the lower oesophageal sphincter (TLOSR), (b) a transient increase in intra-abdominal pressure which overcomes the resistance of the antireflux barrier ('stress reflux') and, (c) a spontaneous reflux through a permanently hypotonic sphincter. Gastric distension is the major factor that can induce TLOSRs. Whereas, at rest, the diaphragm probably plays little role in cardial competence, diaphragmatic contraction may help prevent reflux in conditions resulting in increased abdominal pressure such as during physical activity and abdominal staining. The presence of a hiatal hernia increases susceptibility to reflux. A delayed gastric emptying may also facilitate reflux and represents a factor of resistance to antireflux therapy. Most studies in humans have shown that motor abnormalities remain unchanged after healing of oesophagitis. Acid and pepsin are the most noxious agents of the upper gastrointestinal secretions that can participate in the pathogenesis of oesophagitis. However, there is no evidence that patients with reflux have greater acid secretion than subjects without reflux. The clearance function is a two-stage phenomenon requiring first a reduction in volume by peristalsis and then chemical neutralization by saliva. Primary peristalsis is mainly responsible for the clearance of acid in both the upright and the supine positions. It takes longer to clear acid in patients with non-reducing hiatal hernia. The layer of mucus which carpets the mucosa comes from the saliva and also from the submucosal glands of the oesophagus. The paracellular pathway is the major route by which mucosal HCl enters and then damages the oesophageal epithelium. Only a minority of acid reflux episodes are accompanied by symptoms. The acid exposure during the time period that precedes a reflux episode (i.e. the acid burden) is a key factor determining whether that reflux episode will be symptomatic or asymptomatic.

Entities:  

Mesh:

Year:  1995        PMID: 8545632     DOI: 10.3109/00365529509090286

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  11 in total

1.  Outcome after laparoscopic fundoplication is not dependent on a structurally defective lower esophageal sphincter.

Authors:  M P Ritter; J H Peters; T R DeMeester; P F Crookes; R J Mason; L Green; L Tefera; C G Bremner
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.452

Review 2.  Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?

Authors:  J Labenz; P Malfertheiner
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

3.  Gastroesophageal reflux disease and physical activity.

Authors:  Pawel Jozkow; Dorota Wasko-Czopnik; Marek Medras; Leszek Paradowski
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

4.  Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

5.  Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection.

Authors:  T Rokkas; S D Ladas; C Liatsos; E Panagou; A Karameris; S A Raptis
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

6.  Esophageal swallowing phase assessed by audiosignal recording: relationship with manometry in gastroesophageal reflux disease patients.

Authors:  M Boiron; P Rouleau; B Atipo; L Picon; E H Metman
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

7.  Role of duodenogastroesophageal reflux in the pathogenesis of esophageal mucosal injury and gastroesophageal reflux symptoms.

Authors:  Xiao-rong Xu; Zhao-shen Li; Duo-wu Zou; Guo-ming Xu; Ping Ye; Zhen-xing Sun; Qing Wang; Yan-jun Zeng
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

Review 8.  What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.

Authors:  David Y Graham
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

9.  Is obesity associated with gastropharyngeal reflux disease?

Authors:  Cheol Woong Choi; Gwang Ha Kim; Chul Soo Song; Soo Geun Wang; Byung Joo Lee; Hoseok I; Dae Hwan Kang; Geun Am Song
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

10.  Abdominal obesity and the risk of esophageal and gastric cardia carcinomas.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.